North America Demand for Veterinary Oncology Market to Incur Considerable Upsurge During 2024– 2030: Grand View Research Inc.

 North America Veterinary Oncology Market Growth & Trends

The North America veterinary oncology market size is expected to reach USD 1.22 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 10.86% from 2024 to 2030. The market is driven by the rising incidence of cancer in pets, the number of veterinary clinical trials investigating the safety and effectiveness of various oncologic therapies, and the increasing penetration of pet insurance. Moreover, increasing strategic initiatives for R&D of targeted therapies for cancer in companion animals is boosting market growth. For instance, in July 2023, Ardent Animal Health partnered with FidoCure to expand access to oncology innovation in veterinary medicine by leveraging the latter's genomic testing and precision medicine platform.

During COVID-19, the market witnessed dampened growth owing to several challenges. The pandemic impacted veterinary cancer research & development efforts and the logistics supply of crucial pet pharmaceuticals. It also limited access to veterinary care. According to the Global Animal Health Association's 2020 report, pet owners in a study said that in many countries, veterinarian services were hampered by delayed or skipped care for pets. The pandemic, however, also accelerated the adoption of digital technologies to enhance care. In March 2020, PetCure Oncology upgraded its Telehealth options to enable pet families and referring veterinarians to remotely connect with its board-certified radiation oncologists.

The market is fragmented and competitive due to the presence of several small-to-large market players. Players are actively involved in deploying strategic initiatives to gain market share. For instance, in January 2022, Dechra acquired the rights to sell, market, and support Laverdia-CA1 (verdinexor tablets) in the U.S. from Anivive Lifesciences, Inc. In June 2022, Boehringer Ingelheim International GmbH entered into a research partnership with CarthroniX, a biopharma company, to develop small molecule therapeutics in canine oncology. In April 2023, Torigen Pharmaceuticals partnered with Veterinary Management Groups (VMG) to provide their experimental autologous prescription products and services to the latter's more than 2,000 member clinics network.

Request a free sample copy or view report summary: North America Veterinary Oncology Market Report

North America Veterinary Oncology Market Report Highlights

• Based on animal type, the canine segment dominated the market in 2023 with a revenue share of over 86%. The feline segment, on the other hand, is projected to grow at the fastest CAGR of over 12.55% over the forecast period. This is attributed to the increasing partnerships and collaborations to further the development and launch of reliable veterinary cancer therapies. In October 2022, Ardent Animal Health, for example, completed a license agreement for a novel checkpoint inhibitor for canine cancer treatment
• In terms of therapy, the surgery segment dominated the market in 2023 with a revenue share of over 36%. The immunotherapy segment is projected to grow at the fastest CAGR of 12.91% over the forecast period
• Based on cancer type, the skin cancers segment dominated the market in 2023 with a revenue share of over 39%. The others segment is projected to grow at the fastest CAGR of over 12% over the forecast period
• Based on country, the U.S. held the largest revenue share in the market in 2023, while Canada is anticipated to grow at a CAGR of over 11% over the forecast period. The growth in the U.S. is attributed to the presence of key players and strategic initiatives by market players. In April 2023, Torigen Pharmaceuticals opened a new production facility and headquarters in Farmington, Connecticut, U.S.

Access Press Release@ https://www.grandviewresearch.com/press-release/north-america-veterinary-oncology-market-analysis

North America Veterinary Oncology Market Segmentation

Grand View Research has segmented the North America veterinary oncology market report based on animal, therapy, cancer type, and country

North America Veterinary Oncology Animal Type Outlook (Revenue, USD Million, 2018 - 2030)

• Canine
• Feline
• Equine

North America Veterinary Oncology Therapy Outlook (Revenue, USD Million, 2018 - 2030)

• Radiotherapy
  • Stereotactic Radiation Therapy
    • LINAC
    • Other Types
  • Conventional Radiation Therapy
• Surgery
• Chemotherapy
• Immunotherapy
• Other Therapies

North America Veterinary Oncology Cancer Type Outlook (Revenue, USD Million, 2018 - 2030)

• Skin Cancers
• Lymphomas
• Sarcomas
• Others

North America Veterinary Oncology Country Outlook (Revenue, USD Million, 2018 - 2030)

• US.
• Canada
• Mexico

List of Key Players of North America Veterinary Oncology Market

• Zoetis
• IDEXX
• Antech Diagnostics, Inc. (Mars Inc.)
• Thermo Fisher Scientific Inc.
• Neogen Corporation
• Gold Standard Diagnostics (Eurofins Technologies)
• Bio-Rad Laboratories, Inc
• Ring BioTherapy Co Ltd.
• QIAGEN N.V.
• BIONOTE

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Construction Anchors Market to Expand at a CAGR of 3.9% Through 2030: Grand View Research Inc.

 Construction Anchors Market Growth & Trends

The global construction anchors market size is expected to reach USD 3.90 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 3.9% from 2024 to 2030 This growth can be attributed to the surging demand for advanced construction anchors and fasteners for connecting structural elements. Moreover, the development of new and innovative products and hassle-free installation techniques has considerably driven the market. They are commonly used to fasten structural elements such as columns, beams, equipment, machinery, and other heavy loads.

Mechanical anchors are majorly used for fastening elements of main structural concrete such as slabs, beams, and columns. Torque-controlled expansion anchors are the most commonly used mechanical anchors owing to their quick installation time and easy application. Chemical anchors consist of bonding material and an embedded metal part placed in a pre-drilled hole in the base material. The growing demand for products in the construction industry arises from the need to address current construction problems as well as future innovative structural designs. Presently, the problems include widespread infrastructural decay, which is attributed to the durability of construction materials in concrete structures.

The rapidly expanding construction industry is driving market demand. The increasing focus on advanced architectural design in the construction sector is projected to create potential demand for innovative buildings over the forecast period. The economic development across rapidly developing countries, including China and India, is projected to accelerate market growth over the forecast period.

The players in the construction anchors industry sell their products through a distribution channel, their supplier network, or through sales offices present around the world. The manufacturers are involved in the production of various types of construction anchors, such as concrete screws, lag shields, hammer-set anchors, plastic wall plugs, and anchor bolts. The manufacturers also create their websites or sell their products through third-party websites to expand their presence in other countries.

The need to overcome the limitations of mechanical anchor, such as its expansion against the size of the sides of the hole, is a major challenge in the global construction anchor industry. This expansion induces compression stress, which requires a sufficient amount of base material that can withstand the evolved stress. This pose is a major challenge that needs to be overcome in the upcoming products by the manufacturers to grow their market share. 

Request a free sample copy or view report summary: Construction Anchors Market Report

Construction Anchors Market Report Highlights

• Among products, the mechanical segment dominated the market with 45.3% in terms of revenue in 2023. High durability and rigidity, along with ease of maintenance offered by construction anchors, lead to their surged adoption in the construction industry around the world. Moreover, they are less sensitive to poor installer techniques and can be loaded immediately into the concrete structures. These factors are also anticipated to surge their consumption in commercial and industrial establishments in the coming years.
• Stainless steel anchors dominated the industry and accounted for 53.0% of the overall demand in 2023. However, stainless steel is expected to witness lower growth as compared to its counterpart owing to the increasing penetration of carbon steel anchors in applications such as light poles, highway signs, heavy equipment, and bridge rails on account of their high corrosion resistance and strength-to-weight ratio. However, the high mechanical strength offered by stainless steel anchors is expected to be an important factor triggering their steady growth over the forecast period.
• Commercial buildings led the global market in 2023 by accounting for a revenue share of 31.0% of the overall market. Construction anchors are widely used in commercial applications owing to their ability to provide a secure mounting system to safely hang items to concrete, brick, or block walls. The flourishing commercial sector in developing economies, such as India, Mexico, Brazil, and Indonesia, with required regulatory support in terms of permits for building materials, is expected to fuel the demand for different construction anchors in commercial applications over the forecast period.
• The Asia Pacific construction anchors industry is expected to grow at the fastest CAGR of 4.4% in terms of revenue over the forecast period, owing to a positive outlook toward the overall product demand in the region. Moreover, the penetration of multinational brands backed by favorable trade policies is contributing to the growth of the construction sector in Asia Pacific. The consequent rise of office spaces, factories, manufacturing plants, and infrastructural development projects across the region is likely to propel the demand for construction anchors.
• The market is highly competitive owing to the presence of a large number of manufacturers. Prominent suppliers are focusing on achieving optimal operational costs, maximizing the efficiency of production facilities, attaining shortened lead times, and enhancing the quality of products to maintain their dominance in the market. A major challenge faced by the competitors is the fluctuation of raw material prices; hence, a high degree of backward and forward integration is likely to be observed among the major players in the market. This will further intensify the market rivalry and competition, making it difficult for emerging players to sustain in the market.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-construction-anchors-market

Construction Anchors Market Segmentation

Grand View Research has segmented the global construction anchors market based on product, material, end use, and region:

Construction Anchors Product Outlook (Revenue, USD Million, 2018 - 2030)

• Hangers
• Mechanical
  • Cast-in Anchors
  • Post-installed Anchors
    • Screw
    • Expansion
    • Undercut
  • Chemical
  • Nail-in
  • Wall
  • Other Products

Construction Anchors Material Outlook (Revenue, USD Million, 2018 - 2030)

• Stainless Steel
• Carbon Steel
• Other Materials

Construction Anchors End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Residential
• Commercial
• Industrial
• Infrastructural

Construction Anchors Regional Outlook (Revenue USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Nordic Region
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
• Central & South America
  • Brazil
  • Chile
  • Argentina
• Middle East & Africa
  • Saudi Arabia
  • UAE

List of Key Players in the Construction Anchors Market

• Hilti Corporation
• Stanley Black & Decker, Inc.- DEWALT
• Illinois Tool Works, Inc.
• Wurth Group
• Fischer Fixings UK Ltd.
• Mechanical Plastics Corp.
• Cobra Anchors
• MKT Fastening, LLC
• SFS Group Fastening Technology Ltd.
• Friulsider S.P.A.
• Sika AG
• Koelner Rawlplug IP
• Guangdong Kin Long Hardware Products Co., Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Therapeutic Respiratory Devices Market to Witness Exponential Growth by 2030: Grand View Research Inc.

 Therapeutic Respiratory Devices Market Growth & Trends

The global therapeutic respiratory devices market size is anticipated to reach USD 28.0 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.10% from 2023 to 2030. A growing geriatric population, rapid technological advancements, and increasing prevalence of respiratory diseases are the key factors that are driving the market. Moreover, the market is expected to grow owing to rapid technological advancements in the healthcare sector. Nowadays, respiratory monitoring devices use software applications for the collection and analysis of data from ventilators equipped with the health system.

Availability of ventilation facilities during the COVID-19 outbreak improved day-to-day operational capabilities. The American Association for Respiratory Care joined forces with different organizations to train respiratory therapists on operating ventilators in the pandemic. This has further stimulated the market players to increase their production capacity to meet the additional demand. For instance, Royal Philips presented an update on its goals to double hospital ventilator production by May 2020 and reach a four-fold growth by the third quarter of 2020

Growing prevalence of respiratory diseases is one of the high-impact rendering drivers of this market. According to WHO, 3.23 million people died due to COPD, and it was the third-largest cause of death worldwide in 2019. Likewise, WHO also estimates that by 2030, the four primary potentially fatal respiratory diseases-lung cancer, tuberculosis, COPD, & pneumonia-will cause approximately one in five deaths globally, up from one-sixth of all deaths in the world in 2008.

Furthermore, growing initiatives by government and private organizations, such as COPD Foundation that encourage awareness regarding respiratory illnesses & available treatments, are creating significant potential opportunities in the market. Omron Healthcare India and Lupin Limited established a long-term strategic partnership in June 2020 to improve respiratory disease treatment programs in India, with a primary focus on patients with asthma and COPD. This collaboration will usher in a new era in terms of improving drug delivery, adherence, diagnosis, and awareness.

Request a free sample copy or view report summary: Therapeutic Respiratory Devices Market Report

Therapeutic Respiratory Devices Market Segmentation

• Oxygen concentrators segment dominated the market with the largest share of 29.3% in 2023. Growing demand for home oxygen therapy, rising incidence of respiratory diseases, rapid growth in the aging population, high tobacco consumption, and technological advancements in respiratory devices are some of the reasons driving the segment.
• Electrostatic filters segment dominated the market, with the largest share of 35.7% in 2023. Electrostatic filters provide effective microbial removal and offer low airflow resistance.
• Ventilator filters segment dominated the market with the largest share in 2023. Ventilator filters are crucial for preventing the spread of infectious diseases in healthcare settings.
• North America dominated the market and accounted for a revenue share of 41.2% in 2023. The increasing prevalence of respiratory conditions and technological advancements in respiratory devices, such as portable and compact models with enhanced features is driving the market in the region.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-therapeutic-respiratory-devices-market

Therapeutic Respiratory Devices Market Segmentation

Grand View Research has segmented the global therapeutic respiratory devices market on the basis of product, technology, filter, and region:

Therapeutic Respiratory Devices Product Outlook (Revenue, USD Million, 2018 - 2030)

• Nebulizers
  • Compressor-based Nebulizers
  • Piston based hand held nebulizer
  • Ultrasonic Nebulizer
• Humidifiers
  • Heated Humidifiers
  • Passover Humidifiers
  • Integrated Humidifiers
  • Built-In Humidifiers
  • Stand-alone Humidifiers
• Oxygen Concentrators
  • Fixed Oxygen Concentrators
  • Portable Oxygen Concentrators
• Positive Airway Pressure Devices
  • Continuous Positive Airway Pressure Devices
  • Auto-titrating Positive Airway Pressure Devices
  • Bi-level Positive Airway Pressure Devices
• Ventilators
  • Adult Ventilators
  • Neonatal Ventilators
• Capnographs
• Gas Analyzers

Therapeutic Respiratory Devices Technology Outlook (Revenue, USD Million, 2018 - 2030)

• Electrostatic Filtration
• HEPA Filter Technology
• Hollow Fiber Filtration
• Microsphere Separation

Therapeutic Respiratory Devices Filter Outlook (Revenue, USD Million, 2018 - 2030)

• Nebulizer filters
  • Inlet filter
  • Replacement filter
  • Cabinet filter
• Humidifier filters
  • Wick filters
  • Permanent cleanable filters
  • Mineral absorption pads
  • Demineralization cartridges
• Positive airway pressure devices filter
  • Ultra-fine foam inlet filters
  • Polyester non-woven fiber filters
  • Acrylic & Polypropylene fiber filters
• Oxygen concentrator filters
  • HEPA Filter
  • Cabinet Filter
  • Pre-Inlet Filter
  • Inlet Filter
  • Micro Disk Filter
  • Felt Intake Filter
  • Bacterial Filter
  • Hollow-membrane Filter
• Ventilator filters
  • Mechanical filters
    • HEPA Filters
    • ULPA Filters
    • Activated Carbon Filters
  • Electrostatic filters
    • Tribocharged Filters
    • Fibrillated Filters

Therapeutic Respiratory Devices Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Sweden
  • Denmark
  • Norway
  • Switzerland
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players of Therapeutic Respiratory Devices Market

• GE Healthcare
• Koninklijke Philips N.V.
• ICU Medical (Smiths Medical)
• Invacare Corporation
• React Health
• Medtronic
• Fisher & Paykel Healthcare
• ResMed; CAIRE, Inc. (NGK SPARK PLUG CO., LTD.)
• Linde
• Mindray
• Chart Industries
• Drägerwerk AG & Co. KGaA
• Drive DeVilbiss International
• Inogen, Inc.,
• Novartis International AG
• Hamilton Medical.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Europe Veterinary Antibiotics Market to Exhibit Impressive Growth During 2024– 2030: Grand View Research Inc.

 Europe Veterinary Antibiotics Market Growth & Trends

The Europe veterinary antibiotics market size is expected to reach USD 1.34 billion by 2030, registering a CAGR of 2.25% during the forecast period, according to a new report by Grand View Research, Inc. The rising focus on animal-only antibiotics and ionophores, the launch of new products, and the increasing use of veterinary antibiotics are some of the major factors augmenting the industry's growth. In addition, the rising prevalence and incidence of livestock diseases and concerns regarding zoonoses are further propelling the industry's growth. The COVID-19 pandemic has affected the veterinary antibiotic business operations of key players and resulted in declined financial performance during the initial time.

The effect of the pandemic with various production and supply chain bottlenecks delayed the delivery of necessary raw materials or active ingredients and postponed certain research & development activities. However, with the easing of restrictions, manufacturers were able to supply antibiotics to meet the necessary veterinary requirements. Few major players have reported significant growth in antibiotic sales despite the pandemic. For instance, Virbac’s bovine antibiotic sales grew from USD 66.98 million in 2020 to USD 79.30 million in 2021. The global concern regarding antibiotic resistance is growing in agriculture and veterinary medicine. Despite the regulatory changes implemented by the European Medicines Agency (EMA) for restriction and ban on routine antibiotic use, the overall sales of veterinary antimicrobial active ingredients have observed significant growth in the past few years.

For instance, according to the EMA, overall veterinary antimicrobial active substance sales grew from 5,282 tonnes in 2019 to 5,562 tonnes in 2020. Furthermore, major players, such as Elanco, have shifted their focus to animal-only antibiotics, as a measure to address antibiotic resistance while also protecting animal health. Key players are implementing various strategic initiatives, such as mergers, partnerships, acquisitions, collaborations, and new product launches, to maintain their competitive edge. For instance, in December 2021, Virbac, in collaboration with Pharmgate, launched Tulissin, an antibiotic solution for swine and cattle with respiratory pathologies. These activities are expected to intensify the competition between major antibiotic manufacturers in the coming years.

Request a free sample copy or view report summary: Europe Veterinary Antibiotics Market Report

Europe Veterinary Antibiotics Market Report Highlights

• The cattle animal type segment accounted for the largest revenue share in 2023 owing to the easy availability of cattle antibiotics and increased consumption of beef & dairy products
• By drug class, the penicillin segment held the largest revenue share in 2023. Penicillinis one of the most commonly sold antibiotic drug classes in Europe for veterinary application
• The oral solution segment led the market in 2023 owing to the easy & convenient usage of these dosage forms. These solutions are preferably dispensed in the drinking water
• Key factors contributing to the notable share of the U.K. include the easy availability of veterinary antibiotics and an increase in pet ownership & pet insurance rates
• The industry is fairly competitive owing to the presence of major players. Various strategic initiatives implemented by companies are greatly contributing to the growth of the industry.

Access Press Release@ https://www.grandviewresearch.com/press-release/europe-veterinary-antibiotics-market-analysis

Europe Veterinary Antibiotics Market Segmentation

Grand View Research has segmented the Europe veterinary antibiotics market based on animal type, drug class, dosage form, and country:

Europe Veterinary Antibiotics Animal type Outlook (Revenue, USD Billion, 2018 - 2030)

• Pigs
• Cattle
• Sheep & Goats
• Poultry
• Others

Europe Veterinary Antibiotics Drug class Outlook (Revenue, USD Billion, 2018 - 2030)

• Tetracyclines
• Penicillins
• Sulfonamides
• Macrolides
• Trimethoprim
• Lincosamides
• Polymyxins
• Aminoglycosides
• Fluoroquinolones
• Pleuromutilins
• Other Drug Class

Europe Veterinary Antibiotics Dosage form Outlook (Revenue, USD Billion, 2018 - 2030)

• Oral Powders
• Oral Solutions
• Injections
• Other Dosage Forms

Europe Veterinary Antibiotics Country Outlook (Revenue, USD Billion, 2018 - 2030)

• Germany
• UK
• Netherlands
• Belgium
• Denmark
• France
• Italy
• Spain
• Hungary
• Poland
• Portugal
• Romania
• Sweden
• Norway
• Rest of Europe

List of Key Players in the Europe Veterinary Antibiotics Market

• Merck & Co., Inc.
• Ceva Sante Animale
• Vetoquinol
• Zoetis Services LLC
• Boehringer Ingelheim International GmbH
• Dechra Pharmaceuticals PLC
• Elanco Animal Health Incorporated
• Virbac S.A.
• Calier
• Bimeda, Inc.
• Prodivet Pharmaceuticals SA/NV
• Norbrook Laboratories

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

FemTech Market Strong Application and Emerging Trends also Scope by 2030: Grand View Research Inc.

 FemTech Market Growth & Trends

The global FemTech market size is anticipated to reach USD 97.25 billion by 2030, expanding at a CAGR of 16.30% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rising number of women’s health issues and growing health consciousness indicates the growth potential of the market.

The increasing awareness about health among women and the proactive approach to addressing women's health issues will lead to significant market growth. Factors such as rising digital literacy, disposable income, widespread smartphone and internet use, digital health infrastructure, and the emergence of startups focusing on women's health are creating lucrative opportunities for both new and existing market players. The availability of smart wearable devices is also contributing to market development and growth. Health technology developers and investors are taking advantage of previously untapped opportunities and funding innovative product development strategies to address women's health issues.

Furthermore, the strategic initiatives by the major market players are anticipated to increase market growth during the forecast period. For instance, in June 2022, Flo Health launched Flo for Business, an inclusive strategy focused on women's health for employees. This new employee benefit provides comprehensive, science-based guidance on various reproductive health issues at every stage of life. The introduction of women's health apps aimed at educating and empowering employees to monitor their menstrual cycles, fertility, and overall reproductive health is expected to increase the adoption of such apps, thereby boosting the growth of the market.

FemTech solutions received significant exposure and witnessed a dramatic adoption rate by the healthcare fraternity and female users in maintaining lifestyles and understanding their bodies better. According to a study published in the Maternal and Child Health Journal in 2021, it stated approximately 77.9% of female respondents were using pregnancy care management apps during the pandemic. Market players are constantly focusing on their strategic initiatives to expand their competitive edge in the market. In addition, as per an article published in Fierce Healthcare, the FemTech industry attracted high investments in 2020. The digital health startups focused on women witnessed an increase in funding by around 105% in 2020. Hence, the COVID-19 pandemic impacted the market growth, and the market is estimated to witness an upward trend in the post-pandemic period.

Request a free sample copy or view report summary: FemTech Market Report

FemTech Market Report Highlights

• In terms of type, the devices segment dominated the market with a revenue share of 33.29% in 2023. This dominance reflects the increasing reliance on advanced medical devices tailored specifically for women's health needs, driven by rapid technological advancements in diagnostics and treatment options
• Based on the application, pregnancy and nursing care segment accounted for the largest revenue share in 2023. This growth is attributed to growing recognition of the importance of maternal health, which has led to a greater demand for tailored FemTech solutions that address specific health needs during pregnancy and nursing
• Based on the end-use, direct to consumer segment accounted for the maximum revenue share in 2023. The growth for the direct-to-consumer segment is expected to remain strong, with continuous innovations and increased funding for FemTech solutions that empower women to manage their health more effectively
• North America dominated the market in 2023, owing to improving digital health infrastructure, rising healthcare IT expenditure, growing smartphoneintegration, and the emergence of startups
• Flo is the most downloaded/subscribed app, with over 200 million downloads by 2021. This app majorly caters to period & fertility tracking
• Natural Cycles ad Clue are a few FDA approved digital contraceptive apps that use Bayesian modeling for the prediction of the most fertile days (The high-risk window)
• In February 2023, an AI-based chat application Ema app, previously called SocialMama inspired by ChatGPT has been released by a women's health start-up in Texas. Such advancements help in the increased adoption of FemTech apps, driving market growth in the region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-femtech-market

FemTech Market Segmentation

Grand View Research has segmented the global FemTech market on the basis of type, application, end-use, and region:

FemTech Type Outlook (Revenue, USD Million, 2018 - 2030)

• Devices
• Software
• Services
• Consumer Products

FemTech Application Outlook (Revenue, USD Million, 2018 - 2030)

• Pregnancy and Nursing Care
• Reproductive Health & Contraception
• Menstrual Health
• General Health
• Pelvic & Uterine Health
• Sexual Health
• Womens Wellness
• Menopause Care
• Longevity & Mental Health

FemTech End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Direct to Consumer
• Hospitals
• Surgical Centers
• Fertility Clinics
• Diagnostic Centers
• Others

FemTech Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Russia
  • Iceland
  • Finland
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
  • Singapore
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Israel

List of Key Players in FemTech Market

• Chiaro Technology Limited
• HeraMED
• Flo Health, Inc.
• Natural Cycles USA Corp
• Glow, Inc
• Allara Health
• NUVO Inc.
• Bloomlife
• Syrona Health
• Sirona Hygiene Private Limited
• Samplytics Technologies Private Limited
• iSono Health, Inc.
• Athena Feminine Technologies

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Electronic Health Records Market Predicted to Witness Steady Growth During the Forecast Period: Grand View Research Inc.

 

Electronic Health Record Market Growth & Trends

The global electronic health records market size is anticipated to reach USD 43.36 billion by 2030, growing at a CAGR of 4.43% from 2024 to 2030, according to a new report by Grand View Research, Inc. This is due to the increasing adoption of Electronic Health Records (EHRs) for data collection. This data is used to improve patient care by enabling clinicians to identify specific patterns in populations suffering from diseases and make better clinical decisions. Additionally, the use of analytical tools on this data helps predict risk for hospitalizations or readmissions boosting the demand for advanced EHR solutions.

Furthermore, the increasing use of cloud-based EHR systems is expected to drive market growth. Cloud-based EHRs offer numerous advantages over traditional web-based systems, making them highly appealing to healthcare providers. These benefits include easy implementation, cost savings, reduced IT resource requirements, improved accessibility and collaboration, and simplified scalability.

Moreover, cloud-based EHRs enhance data security and tackle interoperability and data exchange challenges, further increasing their adoption. For instance, in August 2023, Microsoft Corp announced a new partnership that allows Epic Systems Corporation clients, first with Mount Sinai Health System, to use Microsoft Azure Large Instances. This would precisely benefit larger Epic electronic health record (EHR) databases, offering support for over 50 million database entries per second with dedicated resources. This new solution enables Mount Sinai and other Epic clients to overcome the restrictions of previously used shared public cloud infrastructures. 

Request a free sample copy or view report summary: Electronic Health Records Market Report

Electronic Health Records Market Report Highlights

• Based on product, the web & cloud based EHR segment dominated the overall revenues share as of 2023 and is projected to witness lucrative growth over the forecast period. A high adoption rate by physicians is expected to boost the market growth.
• Based on type, the acute segment dominated the market in 2023. The growth is attributed to the government initiatives for the adoption of EHRs in small-scale facilities.
• Based on end use, the ambulatory use segment which includes physician clinics, laboratories, and pharmacies is expected to exhibit the fastest growth over the forecast period owing to the increasing number of ambulatory care centers globally.
• In terms of business model, the professional services segment dominated the market in 2023 and is expected to grow at the fastest CAGR during the forecast period. Professional services help healthcare systems in the implementation of information systems in their organizations.
• Based on application, the cardiology segment held the largest market share in 2023. The growth of this segment is driven by the increasing incidence of hospitalization of patients diagnosed with cardiovascular diseases such as coronary heart disease and stroke
• North America held a major market share as of 2023, due to the presence of well-established healthcare infrastructure as well as favorable government initiatives regarding population health management. 

Access Press Release@ https://www.grandviewresearch.com/press-release/global-electronic-health-records-market

Electronic Health Records Market Segmentation

Grand View Research has segmented the global electronic health record (EHR) market based on product, type, business models, application, end-use, and region:

Electronic Health Records Product Outlook (Revenue, USD Million, 2018 - 2030)

• On-premises
• Web & Cloud-Based EHR

Electronic Health Records Type Outlook (Revenue, USD Million, 2018 - 2030)

• Acute
• Outpatient
• Post Acute

Electronic Health Records Business Model Outlook (Revenue, USD Million, 2018 - 2030)

• Licensed Software
• Technology Resale
• Subscriptions
• Professional Services
• Others

Electronic Health Records Application Outlook (Revenue, USD Million, 2018 - 2030)

• Cardiology
• Neurology
• Radiology
• Oncology
• Mental and Behavioral Health
• Nephrology and Urology
• Gastroenterology
• Pediatrics
• General Medicine
• Physical Therapy and Rehabilitation
• Others

Electronic Health Records End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospital
• Ambulatory Surgical Centers
• Other End Use

Electronic Health Records Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players in the Electronic Health Records Market

• Cerner Corporation (Oracle)
• GE Healthcare, Veradigm LLC (Allscripts Healthcare, LLC)
• Epic Systems Corporation
• eClinicalWorks, Greenway Health, LLC
• NextGen Healthcare, Inc.
• Medical Information Technology, Inc. (Meditech)
• CPSI, AdvancedMD, Inc.
• CureMD Healthcare
• McKesson Corporation

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Eye Health Supplements Market Valuation to Reach $2.94 Billion by the end of 2030: Grand View Research Inc.

 Eye Health Supplements Market Growth & Trends

The global eye health supplements market size is expected to reach USD 2.94 billion by 2030, expanding at a CAGR of 7.06%, according to a new report by Grand View Research, Inc. Rising elderly population, growing exposure to blue light, and increasing prevalence of various vision disorders such as macular degeneration, refractive errors, cataract, inflammation, diabetic retinopathy, corneal opacity, trachoma, and dry eye syndrome are the major factors driving the market. In addition, uneven quality of eye care services, workforce shortages, lifestyle changes leading to less time spent outdoors, poor nutritional habits and dropping food quality, and increasing awareness regarding eye health is further boosting the market growth.

According to the World Health Organization, in 2019, 2.2 billion people were suffering from vision impairments or blindness globally, out of which 1.0 billion people have moderate to severe distance vision impairment. This is owing to unaddressed cataract accounting for 65.2 million, refractive error accounting for 123.7 million, glaucoma accounting for 6.9 million, diabetic retinopathy accounting for 3.0 million, trachoma accounting for 2.0 million, and corneal opacities accounting for 4.2 million, as well as near vision impairment caused due to unaddressed presbyopia accounting for 826.0 million cases. This has led to the rise in the demand and adoption of the supplements for the prevention of various vision-related problems.

Moreover, an increase in the number of product launches, partnerships, collaborations, mergers and acquisitions, and government initiatives is further boosting the market growth. For instance, in November 2019, NovaBay Pharmaceuticals, Inc. announced the launch of NovaSight, formulated to support ocular health, on Amazon.com. In January 2020, VisiVite announced the launch of two new supplements- VisiVite Blue Light Basher Formula for replenishing the macular pigment layer and dissipating high energy blue light, and VisiVite AREDS 2 Chewable Tablets for maximum ocular nutrition. However, lack of product availability and high costs associated with the supplements in emerging countries is anticipated to hamper the market growth.

Request a free sample copy or view report summary: Eye Health Supplements Market Report

Eye Health Supplements Market Report Highlights

• lutein & zeaxanthin ingredients for eye health supplements accounted for the largest revenue share of 33.10% in 2023.
• The Age-related Macular Degeneration (AMD) segment accounted for the largest revenue share in 2023. Whereas, the dry eye syndrome segment is projected to expand at the fastest CAGR during the forecast period.
• Based on formulation, the tablets segment accounted for the largest revenue share in 2023, whereas the softgels segment is projected to expand at the fastest CAGR during the forecast period.
• North America accounted for the largest revenue share in 2023 due to increasing prevalence of eye-related disorders in the region, developed healthcare infrastructure, and a high presence of channel distributors for the supplements.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-eye-health-supplements-market

Eye Health Supplements Market Segmentation

Grand View Research has segmented the global eye health supplements market on the basis of ingredient type, indication, formulation, and region:

Eye Health Supplements Ingredient Type Outlook (Revenue, USD Billion, 2018 - 2030)

• Lutein & Zeaxanthin
• Antioxidants
• Omega-3 Fatty Acids
• Coenzyme Q10
• Flavonoids
• Alpha-Lipoic Acid
• Astaxanthin
• Others

Eye Health Supplements Indication Outlook (Revenue, USD Billion, 2018 - 2030)

• Age-related Macular Degeneration (AMD)
• Cataract
• Dry Eye Syndrome
• Inflammation
• Others

Eye Health Supplements Formulation Outlook (Revenue, USD Billion, 2018 - 2030)

• Tablets
• Capsules
• Powder
• Softgels
• Liquid
• Others

Eye Health Supplements Regional Outlook (Revenue, USD Billion, 2018 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players of Eye Health Supplements Market

• The Nature's Bounty Co.
• Vitabiotics Ltd.
• Pfizer Inc
• Amway International
• Bausch & Lomb
• Nutrivein
• ZeaVision LLC
• Kemin Industries, Inc.
• EyeScience
• Nutrachamps

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Passenger Cars Market Projected to Discern Stable Expansion by 2030

 Passenger Cars Market Growth & Trends

The global passenger cars market size is anticipated to reach USD 9,664.49 billion by 2030, growing at a CAGR of 16.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market growth is attributed to the growing demand for eco-friendly and fuel-efficient vehicles. With increasing concerns about environmental sustainability and the need to reduce carbon emissions, there has been a significant shift towards electric and hybrid vehicles. This shift is driven by stringent government regulations aimed at reducing greenhouse gas emissions, as well as by consumers' increasing preference for cleaner and more sustainable transportation options.

For instance, in August 2022, the California Air Resources Board (CARB) initiated a new rule, The Advanced Clean Cars II, to rapidly increase the number Of Zero-Emission Vehicles (ZEVs) on the road and reduce greenhouse gas emissions from the transportation sector. The rule requires that by 2035, 100% of all new cars sold in California must be ZEVs. In 2026, 35% of all new cars and light trucks sold in California must be ZEVs. This percentage will increase to 50% in 2028, 65% in 2030, and 100% in 2035. As a result, this demand for eco-friendly cars has led to a surge in the development and production of electric and hybrid vehicles by major automotive manufacturers, thereby fueling the demand for passenger cars across the globe.

The global automotive industry has been witnessing a paradigm shift with the increasing investment and development in alternative transportation modes such as high-speed trains, hyperloop technology, and autonomous vehicles. These emerging modes challenge the traditional dominance of passenger cars by offering efficient, cost-effective, and environmentally friendly alternatives. For instance, high-speed trains provide a convenient and rapid transportation, particularly for long-distance travel, thereby reducing the demand for passenger cars, especially for intercity commuting. Additionally, hyperloop technology provides unprecedented speeds, potentially revolutionizing transportation and providing a viable alternative to conventional road travel, which could further dampen the demand for passenger cars. As a result, such factors hamper the market growth to a certain extent.

The rapid development and adoption of Electric Vehicle (EV) technology have significantly influenced the global passenger car market. Factors such as advancements in battery technology have driven the shift toward EVs. This transition has reshaped the automotive landscape and also sparked a wave of innovation across the industry. Additionally, the continuous evolution of battery technology has led to advancements in energy density, charging speed, and overall performance, contributing to the increased acceptance and viability of electric vehicles as a practical alternative to traditional gasoline-powered cars. For instance, in November 2023, Stellantis N.V., an automotive manufacturer and Contemporary Amperex Technology Co., Limited (CATL), a battery manufacturer for electric vehicles signed a Memorandum of Understanding (MoU) for LFP battery cell supply for Stellantis’ electric vehicle production in Europe.

Furthermore, in November 2022, American Battery Factory Inc. (ABF), a battery cell manufacturer, collaborated with Anovion, an advanced material technology company, to supply LFP battery cells with graphite anode components made in the U.S. The collaboration envisaged Anovion being the preferred supplier for ABF's synthetic graphite anode materials and ensuring that this essential battery component is sourced domestically. The two organizations were looking forward to considering long-term collaborations to increase battery efficiency and optimize the supply chain, extending beyond bolstering the domestic supplier base for LFP battery cells.

As the global focus on sustainability and eco-friendly transportation intensifies, the ongoing advancements in electric vehicle technology are poised to continue reshaping the passenger car market and driving further innovation in the automotive industry. Additionally, the increasing emphasis on personalized driving experiences has propelled the demand for vehicles equipped with advanced infotainment systems that offer customization options tailored to individual preferences. The ability to customize features such as audio settings, climate control, and digital assistant integrations within the vehicle enhances the overall appeal of the car, leading to a rise in consumer interest and, subsequently, an increase in demand for such digitally advanced passenger cars globally.

Request a free sample copy or view report summary: Passenger Cars Market Report

Passenger Cars Market Report Highlights

• Based on propulsion type, the electric segment is expected to register the fastest CAGR from 2024 to 2030. The growth of electric passenger cars globally can be primarily attributed to advancements in battery technology, driving improved range and affordability, and a growing infrastructure for electric vehicle charging stations.
• The luxury vehicle class segment is anticipated to register the fastest CAGR from 2024 to 2030. The convergence of luxury and technological innovation has positioned these vehicles as symbols of modernity and sophistication, driving the sustained demand observed across the global luxury car market.
• Based on car type, the sedan segment is anticipated to register the fastest CAGR from 2024 to 2030. The growing emphasis on safety and advanced technological features has prompted many consumers to opt for sedans, as these vehicles often incorporate the latest safety innovations and cutting-edge infotainment systems.
• Asia Pacific is expected to register the fastest CAGR from 2024 to 2030. The growth of passenger cars in Asia Pacific can be primarily attributed to rising urbanization, increasing disposable incomes, and a growing middle class, coupled with a shift in consumer preferences for personal mobility and convenience. Additionally, government initiatives promoting the development of infrastructure, such as improved road networks and favorable policies, have further fueled the expansion of the regional market.
• The global passenger car market remains competitive, characterized by the dominance of key players such as Tesla, Inc.; Toyota; Volkswagen; General Motors; and Ford Motor Company. These industry leaders face intensifying competition from emerging electric vehicle manufacturers such as Tesla and NIO, prompting a shift towards sustainable and technologically advanced offerings to meet evolving consumer preferences and stringent environmental regulations.
• In July 2023, BYD Co. Ltd’s Denza brand revealed a N7 electric SUV. The Denza N7 is a mid-size, five-seater SUV that is positioned as a premium offering in the Chinese electric car market. The N7 is available in two versions namely a single-motor rear-wheel drive model with a range of 540 km (336 miles) and a dual-motor all-wheel drive model with a range of 630 km (391 miles). Both versions use BYD's Blade Battery, which is known for its safety and long lifespan.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-passenger-cars-market

Passenger Cars Market Segmentation

Grand View Research has segmented the global passenger cars market based on propulsion type, vehicle class, type, and region:

Passenger Cars Propulsion Type Outlook (Volume, Units; Revenue, USD Million, 2018 - 2030)

• ICE
• Electric

Passenger Cars Vehicle Class Outlook (Volume, Units; Revenue, USD Million, 2018 - 2030)

• Luxury
• Economy

Passenger Cars Type Outlook (Volume, Units; Revenue, USD Million, 2018 - 2030)

• Hatchback
• MUV
• Sedan
• SUV
• Others

Passenger Cars Regional Outlook (Volume, Units; Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• Latin America
  • Brazil
• MEA
  • UAE
  • Saudi Arabia
  • South Africa

List of Key Players in the Passenger Cars Market

• AUDI AG.
• BMW AG
• Ford Motor Company
• General Motors
• Honda Cars India Limited
• Suzuki
• Hyundai Motor India
• Kia India Pvt. Limited.
• Mercedes-Benz
• Nissan Motor Co., Ltd.
• Renault Group
• TATA Motors
• Tesla
• Volkswagen Group

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Cardiac Mapping Devices Market Latest Trends, Industry Growth And Forecast To 2030: Grand View Research Inc.

 Cardiac Mapping Devices Market Growth & Trends

The global cardiac mapping devices market size is expected to reach USD 3.69 billion by 2030, registering a CAGR of 9.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. The primary factors driving the market expansion include the rising arrhythmia cases & number of cardiac surgery patients, growing geriatric population, technological advancements in cardiac mapping systems, and supportive government initiatives. According to the Heart Rhythm Society article published in August 2023, Atrial fibrillation (AFib), the most common type of cardiac arrhythmia, affects nearly 40 million people worldwide, including 6 million in the U.S. Its widespread prevalence underscores the need for advanced diagnostic and treatment options.

Approximately 1 in 4 adults over 40 are at risk of developing AFib, yet many are unaware of its symptoms, available treatments, and the importance of early intervention to prevent progression. Advancements in cardiac mapping systems also drive market growth. For instance, in June 2024, new mapping techniques, such as multielectrode baskets and catheters mapping across cardiac arteries and veins on the epicardium, enabled three-dimensional activation sequence definition during vacuum therapy. Computerized non-contact mapping uses mathematical algorithms to reconstruct electrograms and generate three-dimensional isopotential maps without direct heart endocardium contact.

Advances in remote monitoring and infection prevention in cardiac electrophysiology support continuous patient heart rhythm monitoring outside clinical settings, allowing prompt treatment adjustments and reducing invasive procedure infection risks. Moreover, several strategic initiatives by key players fuel the market’s growth. For instance, in July 2024, Johnson & Johnson’s Biosense Webster launched the Optrell mapping catheter, incorporating TrueRef technology. Designed in Irvine, California, by Biosense Webster, Optrell is a high-density diagnostic catheter that integrates with the Carto 3 system. It utilizes small electrodes in a fixed array configuration to provide accurate electrophysiological mapping for complex cardiac arrhythmias.

Request a free sample copy or view report summary: Cardiac Mapping Devices Market Report

Cardiac Mapping Devices Market Report Highlights

• T
• he contact cardiac mapping systems segment held the largest share of over 57.07%, in 2023 due to technological advancements, strategic initiatives by key players, and a rising volume of cardiac procedures
• The atrial fibrillationsegment held the largest share of over 45.87% in 2023 due to increased cases of arrhythmia and high geriatric population
• The hospitals segment held the largest share of 69.38% in 2023. Hospitals play a vital role in adopting and assessing new technologies, such as advanced cardiac mapping devices. These devices enable hospitals to deliver state-of-the-art care for patients with cardiac arrhythmias, ensuring better outcomes and advancing the field of electrophysiology
• North America dominated the global market with a share of 41.39% in 2023 owing to the increased cases of cardiovascular diseases (CVDs), including arrhythmias. Product launches, regulatory approvals, and advanced healthcare infrastructure

Access Press Release@ https://www.grandviewresearch.com/press-release/global-cardiac-mapping-devices-market

Cardiac Mapping Devices Market Segmentation

Grand View Research has segmented the global cardiac mapping devices market on the basis of type, indication, end use, and region:

Cardiac Mapping Devices Type Category Outlook (Revenue, USD Million, 2018 - 2030)

• Contact Cardiac Mapping Systems
• Non-Contact Cardiac Mapping Systems

Cardiac Mapping Devices Indication Category Outlook (Revenue, USD Million, 2018 - 2030)

• Atrial Fibrillation
• Atrial Flutter
• Others

Cardiac Mapping Devices End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals
• Diagnostic Centers
• Others

Cardiac Mapping Devices Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Thailand
  • South Korea
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players of Cardiac Mapping Devices Market

• Medtronic
• Abbott
• Boston Scientific Corporation
• Johnson & Johnson
• Koninklijke Philips N.V.
• BIOTRONIK 
• MicroPort Scientific Corporation
• APN HEALTH
• Acutus Medical, Inc.
• Kardium
• BioSig Technologies, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Incontinence And Ostomy Care Products Market Trends Analysis And Forecast Till 2030: Grand View Research Inc.

 Incontinence And Ostomy Care Products Market Growth & Trends 

The global incontinence and ostomy care products market size is anticipated to reach $25.7 Billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.4% from 2024 to 2030. The increasing incidence of colorectal cancer and urological diseases, such as Inflammatory Bowel Disease (IBD), urinary incontinence, and benign prostatic hyperplasia is anticipated to boost the market growth.

The growing risk of colorectal and urinary bladder cancer has increased the demand for ostomy care products. For instance, the American Cancer Society has reported that in 2019, the number of colorectal cases in the U.S. has increased to 101,420. This is expected to drive the growth of the market at a global level.

Increasing awareness initiatives by several market players to raise cognizance regarding these prosthetic medical devices globally is successfully breaking the stigma and taboo associated with the use of these products. For instance, Coloplast is a leading market player and has recently published Ostomy Life Study Review to raise awareness and improve the standard of ostomy care. This helps in effective patient care, building their confidence, and inspires them to live a quality life.

Moreover, the outbreak of COVID-19 has spurred the demand for incontinence products used in home settings. Since the majority of consumers are aged/seniors, there is a higher demand for these products. Restrictions on movement at international borders have created an opportunity for local players to enter the market and meet the unmet demands of the end-users. In November 2020, NorthShore Care Supply announced a free trial of 2 bags of adult diapers and a discount on all absorbents for ICU Nurses or other COVID first responders.

Request a free sample copy or view report summary: Incontinence And Ostomy Care Products Market Report

Incontinence And Ostomy Care Products Market Report Highlights

• Based on type, the incontinence care products segment held the largest revenue share of around 74.9% in 2020. This can be attributed to the increasing cases of urological diseases, such as IBD, colon cancer, and bladder control problems
• The incontinence care products segment is further segmented into absorbents, incontinence bags, and others. Whereas, the ostomy care products segment is sub-divided into ostomy bags, deodorants, skin barriers, and irrigation products
• Europe dominated the market in 2020 with the largest revenue share of around 43.2%, owing to the increasing prevalence of urological diseases, supportive government policies, and increasing awareness programs

Access Press Release@ https://www.grandviewresearch.com/press-release/incontinence-and-ostomy-care-products-market

Incontinence And Ostomy Care Products Market Segmentation

Grand View Research has segmented the global incontinence and ostomy care products market on the basis of type and region:

Incontinence And Ostomy Care Products Type Outlook (Revenue, USD Million, 2018 - 2030)

• Incontinence Care Products
  • Absorbents
  • Incontinence Bags
  • Others
• Ostomy Care Products
  • Ostomy Bags
    • Colostomy Bags
    • Ileostomy Bags
    • Urostomy Bags
  • Deodorants
  • Skin Barriers
  • Irrigation Products

Incontinence And Ostomy Care Products Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Norway
  • Sweden
  • Denmark
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players of Incontinence And Ostomy Care Products Market

• Essity
• Kimberly-Clark Corporation
• Attends Healthcare Products, Inc.
• ABENA A/S
• Coloplast Corp
• Ontex Group
• PAUL HARTMANN AG
• First Quality Enterprises, Inc.
• Hollister Incorporated
• Cardinal Health
• Unicharm Corporation
• Convatec Group PLC
• Braun SE
• BD
• Medline
• Welland Medical Limited
• Salts Healthcare

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.